![]() ![]() |
![]() |
|||
![]() |
||||
|
|
||||||||||||||
|
M/s Lahore Chemical
& Pharmaceutical Works (Pvt.) Ltd; manufacturers of HOWARDS brand
of products has added Ceftazidime, a new product to their antibiotic line,
under the brand of CEFTACIN on May. 2, the company said. Speaking at a Cake cutting ceremony to Howards's Sales force and other attendees including Managing Director, Marketing Manager, Product Manager and Noble Doctors etc., Mr. Asad I. Mumtaz, General Manager Marketing, said. "We're thrilled to offer this new and exciting product to patients, as this has the potential to improve patient compliance and treatment efficacy, HOWARDS is a leading manufacturer of quality medicines, selling a comprehensive range of products across the country. We are dedicated to improving the awareness among patients and healthcare professionals of the potentially serious health consequences, and to developing new molecules to improve the lives of those who suffer from different diseases. Key to its launch strategy, the HOWARDS had an exciting new message to disseminate: this medication is the only antibiotic to protect efficacy in Hospital Acquired infections by minimizing resistance. The molecular makeup of the medication guards against the development of "superbugs," or, antibiotic-resistant germs. This new medication is resistance-resistant. The company is faced with the challenge of successfully launching this new medication to primary care physicians and specialists. The product (Ceftacin) has simultaneously been given in different hospital wards for assessment and to the trade to cater to professional requirements. Ceftacin is available in all the three strengths of 250mg, 500mg, & 1gm for suitability to different age groups of patients. |